Walking in multiple sclerosis improves with tDCS: a randomized, double-blind, sham-controlled study.

There was a clear trend of increase in gait speed and stride length across the 10 treatment sessions in the active tDCS group, with significant measurable differences by the fourth treatment session.

also in 19,460 other papers